Azelaic acid is a dicarboxylic acid that occurs naturally in grains like wheat, barley, and rye, and is also produced by Malassezia yeast on skin. It’s one of the few ingredients that genuinely multitasks – not because it does many things superficially, but because several of its distinct mechanisms converge on overlapping skin concerns.
For hyperpigmentation, it inhibits tyrosinase – specifically, it’s a competitive inhibitor that’s selective for abnormally active melanocytes. Normal melanocytes are largely unaffected at therapeutic concentrations, which means it’s less likely to cause unwanted lightening of areas that aren’t hyperpigmented. This selectivity makes it more predictable than hydroquinone for PIH in darker skin tones.
For acne, it normalises follicular keratinisation (the abnormal cell shedding inside the pore that contributes to comedone formation) and has direct antimicrobial activity against P. acnes and S. epidermidis. A 20% azelaic acid cream showed comparable efficacy to 0.05% tretinoin and 4% erythromycin in controlled trials.
For rosacea, it’s one of few topicals with strong clinical evidence – 15% azelaic acid gel (Finacea) is an approved prescription treatment. The mechanism involves reducing the production of reactive oxygen species and inhibiting the kallikrein-5 enzyme involved in rosacea’s inflammatory cascade.
OTC products typically max out at 10%. Prescription formulations reach 15-20%. The concentration gap matters – 10% works for maintenance and mild concerns; 15-20% is needed for established melasma or moderate rosacea. It’s safe during pregnancy, which is clinically significant given that many first-line alternatives are not.